Longevity
Epitalon
aka Epithalon · Epithalone · AEDG peptide · Ala-Glu-Asp-Gly · Epitalone · epitalon · epithalamin · epitalon peptide
Grade
Epitalon is a lab-made four-amino-acid peptide promoted as an anti-ageing telomere treatment, but the human evidence behind those claims is thin and largely from one research group.
- Class
- Synthetic pineal tetrapeptide (peptide bioregulator)
- Evidence
- Grade D · Animal data only
- Sport / WADA
- Not specifically listed by name on the WADA Prohibited List. Substances are not 'permitted' simply because they are unnamed; novel peptides can fall under broad catch-all categories, so athletes should treat it as high-risk.
- Last reviewed
- 2026-06
Grade D · Animal data only
Why this grade
The evidence base is overwhelmingly cell-culture and animal work, the bulk of it from a single Russian group (Khavinson and colleagues) and rarely independently replicated. The handful of human reports are small, old and methodologically weak. There is no robust human trial showing Epitalon extends lifespan, lengthens telomeres in living people, or treats any disease. This places it firmly at D: an interesting preclinical signal with negligible meaningful human evidence.
What is it?
Epitalon is a tiny man-made peptide (a chain of just four building blocks) based on a substance from the pineal gland, a small organ in the brain. Sellers claim it can switch your body's cells back into a younger mode by protecting telomeres, the caps on the ends of your DNA that wear down as you age. Almost all the encouraging results come from cells in a dish and from mice and rats, mostly produced by one Russian laboratory. The few studies in actual people were small and old. Nobody has run a proper modern trial showing it makes humans live longer or healthier. The anti-ageing story remains a hopeful idea, not a proven fact.
It is like a promising lab notebook that never made it out of the lab. Impressive results on cells in a dish and on mice, written up mostly by one team, but with the crucial does-it-work-in-people chapter still essentially blank.
How is it meant to work?
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modelled on a pineal-gland extract. Proposed to upregulate telomerase (hTERT), lengthen telomeres, modulate gene expression via direct peptide-DNA interaction, and restore pineal melatonin/circadian signalling. These mechanisms are demonstrated mostly in vitro; confirmation in living humans remains lacking.
What's it studied for?
Research contexts. Not proven uses, and not recommendations.
Does the human evidence stack up?
Genuinely thin. Despite decades of publications, human data are limited to a few small, old and methodologically weak studies, including retinitis pigmentosa cohorts and circadian/melatonin observations in elderly subjects. Almost all come from the Khavinson group. There are no modern, adequately powered, independently run randomised controlled trials, and no human study demonstrating telomere lengthening in living people or any extension of human lifespan or healthspan. The dramatic 'anti-ageing' claims rest on cell-culture and rodent work, not on humans.
What could go wrong?
- !Evidence dominated by a single Russian research group with limited independent replication
- !No modern, adequately powered human RCTs; longevity and telomere claims unproven in people
- !Some animal studies show no increase in mean lifespan, undercutting headline claims
- !Sold in the UK as an unlicensed research chemical / not for human consumption. No regulatory oversight of identity, purity, sterility or dose
- !Grey-market injectable products carry contamination, mislabelling and sterility risks
- !Long-term safety in humans is essentially unknown. Theoretical concern attaches to any agent claimed to activate telomerase, given telomerase's role in cancer cells
- !Marketing routinely overstates the evidence as if it were clinically established
Is it legal in the UK?
Not a licensed medicine in the UK and not approved by the MHRA for any use. It is not an authorised medicinal product, so any product making medical claims would contravene the Human Medicines Regulations 2012. In practice it is sold online as an unlicensed research chemical labelled not for human consumption, outside any pharmaceutical quality, safety or efficacy oversight. Supplying it for human use or marketing it with medicinal claims is unlawful.
Sources
- 01Overview of Epitalon - Highly Bioactive Pineal Tetrapeptide with Promising Properties — Bryl R, et al., International Journal of Molecular Sciences (2025)
Recent review; useful for showing the heavy imbalance toward preclinical data and the scarcity of human evidence.
- 02Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice — Anisimov VN, Khavinson VKh, et al., Biogerontology (2003)
Key rodent study; reported reduced tumour incidence and effects on ageing markers but no increase in mean lifespan in that cohort.
- 03Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — Al-Dulaimi S, et al., Biogerontology (2025)
Recent in-vitro work outside the Khavinson group - still cell-line data, not human evidence.
- 04Epitalon (Epithalon) - peptide bioregulator overview, Wikipedia
General background and summary of small human reports (e.g. retinitis pigmentosa); tertiary source, use only as orientation.
Related
Stay posted
Follow Epitalon
We'll email you only when Epitalon's evidence actually changes — a new human trial, a grade change, a safety signal. No spam, nothing for sale.